Day One Biopharmaceuticals is down a bit on the day, funds flowing out kept the price down -2.89% since yesterday. DAWN is near a weak support line. We'll see if it bounces off or heads lower. Day One Biopharmaceuticals hasn't been treated too well by the market over the last few months and has seen a lot of selling continue to drive price down. It might get a little bounce here and that may be
subsequently followed by profit taking. Over the past 3 months, owners of the asset are down -37.58 percent, we'll see if more buyers feel it's appropriately priced and want to purchase, if so we might get a little bounce.
If the price bounces off of the support and moves up it'll probably head up to the $11.69 level, at which point it may hit some selling pressure. There aren't very obvious support levels beneath this point. So put those stop losses on, this thing has room to fall if buyers don't come in at this level.
The analysts are pretty neutral on Day One Biopharmaceuticals right now, so not much useful information here. The current Analysts Sentiment Score is 1.82. Most companies range between (-200 to 200).
Here's a break down of the latest rating changes. JPMorgan Chase & Co. provided a price target boost of 12.5% to $36.00 from $32.00 on 2024-04-22. Piper Sandler reiterated a rating of Overweight on 2024-03-26 and added a price target of $40.00. Oppenheimer reiterated a rating of Market Perform on 2024-02-27. On 2024-02-27 The Goldman Sachs Group lowered their price target by -12% to $44.00. Needham & Company LLC announced that they are reiterating a rating of Buy on 2023-11-07 and they set their price target at $34.00. Wedbush provided a price target decease of -10.26% to $35.00 from $39.00 on 2023-11-07. On 2023-08-08 HC Wainwright reiterated their rating of Buy and added a price target of $50.00. Bank of America released a downgrade on 2023-04-25 from Buy to Underperform.
| Company | Ratings Score
?
Composite analyst sentiment score
|
Positive Ratings | Negative Ratings | Boost Price Target | Lower Price Target |
|---|---|---|---|---|---|
| DAWN | 1.82 | 2.01 | -0.45 | 2.53 | -0.45 |
| Company | YOY Growth Score (typical -20 to +20) | Revision Directions (-6 to +6) |
|---|---|---|
| DAWN | 0.00 | 0.00 |
We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.
| Company | Short Score (typical 1-15)
?
We take into account several different measures and attributes of short interest to create a composite sentiment score. typical range (0 - 30)
|
Short Interest | Days to Cover | Rate of Change | Shares Short |
|---|---|---|---|---|---|
| DAWN | 16.28 | %20.1 | 14.7 | -10.626 | 11350000 |
Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.
| Ticker | Social Sentiment(1-10) |
|---|---|
| DAWN |
How to use: use the research links to research the asset. Then simply type in a score for each category between (01, 02, 03, 04, 05). 05 being the most bullish and 01 being the most bearish. It will automatically calculate the average and combine it with the technical score to create an overall score to rank prospects by. You can also type notes into each field.
